Ganesh Venkataraman Kaundinya - Net Worth and Insider Trading

Ganesh Venkataraman Kaundinya Net Worth

The estimated net worth of Ganesh Venkataraman Kaundinya is at least $26 Million dollars as of 2025-05-12. Ganesh Venkataraman Kaundinya is the COO & CSO of Momenta Pharmaceuticals Inc and owns about 495,145 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $26 Million. Details can be seen in Ganesh Venkataraman Kaundinya's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ganesh Venkataraman Kaundinya has not made any transactions after 2018-08-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ganesh Venkataraman Kaundinya

Ganesh Venkataraman Kaundinya Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ganesh Venkataraman Kaundinya owns 1 companies in total, including Momenta Pharmaceuticals Inc (MNTA) .

Click here to see the complete history of Ganesh Venkataraman Kaundinya’s form 4 insider trades.

Insider Ownership Summary of Ganesh Venkataraman Kaundinya

Ticker	Company	Transaction Date	Type of Owner
MNTA	Momenta Pharmaceuticals Inc	2018-08-21	COO & CSO

Ganesh Venkataraman Kaundinya Latest Holdings Summary

Ganesh Venkataraman Kaundinya currently owns a total of 1 stock. Ganesh Venkataraman Kaundinya owns 495,145 shares of Momenta Pharmaceuticals Inc (MNTA) as of August 21, 2018, with a value of $26 Million.

Latest Holdings of Ganesh Venkataraman Kaundinya

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
MNTA	Momenta Pharmaceuticals Inc	2018-08-21	495,145	52.48	25,985,210

Holding Weightings of Ganesh Venkataraman Kaundinya

Ganesh Venkataraman Kaundinya Form 4 Trading Tracker

According to the SEC Form 4 filings, Ganesh Venkataraman Kaundinya has made a total of 0 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 581 shares on August 21, 2018, which brought Ganesh Venkataraman Kaundinya around $15,832.

Insider Trading History of Ganesh Venkataraman Kaundinya

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ganesh Venkataraman Kaundinya Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ganesh Venkataraman Kaundinya Ownership Network

Ownership Network List of Ganesh Venkataraman Kaundinya

No Data

Ownership Network Relation of Ganesh Venkataraman Kaundinya

Ganesh Venkataraman Kaundinya Owned Company Details

What does Momenta Pharmaceuticals Inc do?

Who are the key executives at Momenta Pharmaceuticals Inc?

Ganesh Venkataraman Kaundinya is the COO & CSO of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief HR and Inf. Officer Jo Ann Beltramello , Chief Scientific Officer Anthony M. Manning , and Chief Legal Officer Alejandra Carvajal .

Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Momenta Pharmaceuticals Inc Insider Transactions

No Available Data

Ganesh Venkataraman Kaundinya Mailing Address

Above is the net worth, insider trading, and ownership report for Ganesh Venkataraman Kaundinya. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ganesh Venkataraman Kaundinya's mailing address is: Inc. 675 West Kendall Street Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.